The University of Pennsylvania plans to continue offering CAR-T therapy, a cancer treatment pioneered at Penn, after the Food and Drug Administration announced an investigation into whether the treatment may cause cancer ...
Nov 29, 2023
0
85
Using a simple concept and a patented Sandia sensor that detects radioactive materials, a team at Sandia National Laboratories has developed a patch to stop damage to healthy tissue during proton radiotherapy, one of the ...
Oct 23, 2023
0
1
Researchers have confirmed that blocking an immune checkpoint molecule reduces tumor size and prolongs survival in animal models of the most aggressive childhood cancer. This study, carried out by researchers from Cima and ...
Oct 11, 2023
0
1
Cancer arises when cells accumulate enough damage to change their normal behavior. The likelihood of accruing damage increases with age because the safeguards in your genetic code that ensure cells function for the greater ...
Oct 10, 2023
0
1
Three out of four children with cancer are successfully treated and survive the disease. But the treatment, which often consists of a combination of surgery, chemotherapy and radiation, can cause serious side effects and ...
Sep 11, 2023
0
14
A new editorial paper titled "Targeting H3K27me3 loss in pediatric brain tumors—a perspective on epigenetically guided cancer therapy" has been published in Oncotarget.
Aug 2, 2023
0
0
A new measurement tool helps analyzing the survival rate of children with cancer, but also the quality of survival. Researchers at the Princess Máxima Center for Pediatric Oncology have worked with patients and survivors ...
Jun 20, 2023
0
22
In a paper published in NAR Cancer, researchers from the Center for Childhood Cancer Research at Nationwide Children's and their collaborators report a comprehensive 3D chromatin structural analysis and characterization of ...
Jun 14, 2023
0
3
Three clinical trials led by researchers at The University of Texas MD Anderson Cancer Center demonstrated positive results from the targeted therapy erdafitinib for patients with multiple tumor types harboring FGFR alterations. ...
Jun 5, 2023
0
2
Biosimilars provide the same therapeutic benefits at much less cost than biologic medications, yet slow marketplace acceptance has prevented their advantages from being fully realized.
May 22, 2023
0
38
